FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890711618> ?p ?o ?g. }

• W2890711618 abstract "e18022 Background: In Russia, there are no federal screening programs for detecting early stage of colon cancer; therefore we can assess the impact of various factors that could potentially affect the mortality of pts with mCRC Methods: We conducted a survey with 13 question according treatment of pts with CRC in 17 regional comprehensive cancer centers in 14 regions of Russia, with a total population of 26.347 billion. Results of the survey were conducted by methods of descriptive statistics. Effects of factors on mortality rate in regions were analyzed by a regression model Results: Only 34% pts with stage II-III received adjuvant chemotherapy. Mutation status of KRAS gene has been evaluated only in 33% pts with mCRC. In 2013, metastasectomy was performed only 13% of pts. Only 80% of pts who needed systemic treatment received chemotherapy (CT): doublets of CT (XELOX/FOLFOX/FLOX or FOLFIRI/XELIRI/IFL) - 49%, monotherapy of fluoropyrimidines - 39% of pts, bevacizumab – in 14% and anti-EGFR antibodies - 5% pts. Only 14% of pts with mCRC was placed central vein devices. Second line CT was performed in 47% pts: doublets – in 54%, monotherapy of fluoropyrimidines - in 24% pts, bevacizumab - 13% and anti-EGFR antibody - 8%. Third-line treatment was performed in 25% of pts: anti-EGFR antibodies - in 7.5%. According to regression analysis adjuvant chemotherapy (р = 0.01), bevacizumab only in the 1 st line (р = 0.01), and installation of central venous devises (р = 0.07) and anti-EGFR antibody in the 1 st line (р = 0.1) in wtKRAS pts had independent positive effect on the mortality rate in regions. We revealed a significant reverse connection between a high mortality rate in the region and administration of fluoropyrimidine monotherapy as 1 st line treatment of metastatic disease (p = 0.01) Conclusions: The mortality with colorectal cancer is depended of complex factors that reflect the health care organization in the region, both at the stage of treatment of pts with early-stage and metastatic disease. We revealed that targeted agents are the most effective only in the 1 st line settings." @default.
• W2890711618 created "2018-09-27" @default.
• W2890711618 creator A5012700479 @default.
• W2890711618 creator A5016431282 @default.
• W2890711618 creator A5019258469 @default.
• W2890711618 creator A5021102458 @default.
• W2890711618 creator A5034100625 @default.
• W2890711618 creator A5036692508 @default.
• W2890711618 creator A5039310160 @default.
• W2890711618 creator A5042375497 @default.
• W2890711618 creator A5043887737 @default.
• W2890711618 creator A5044978887 @default.
• W2890711618 creator A5048786719 @default.
• W2890711618 creator A5050089199 @default.
• W2890711618 creator A5057758368 @default.
• W2890711618 creator A5061298229 @default.
• W2890711618 creator A5062535720 @default.
• W2890711618 creator A5063215262 @default.
• W2890711618 creator A5078527369 @default.
• W2890711618 creator A5079081718 @default.
• W2890711618 creator A5088641329 @default.
• W2890711618 date "2017-05-20" @default.
• W2890711618 modified "2023-09-27" @default.
• W2890711618 title "Evaluation of the quality of cancer treatment in a population of patients (pts) with metastatic colorectal cancer (mCRC) in routine clinical practice in different regions of Russia." @default.
• W2890711618 doi "https://doi.org/10.1200/jco.2017.35.15_suppl.e18022" @default.
• W2890711618 hasPublicationYear "2017" @default.
• W2890711618 type Work @default.
• W2890711618 sameAs 2890711618 @default.
• W2890711618 citedByCount "0" @default.
• W2890711618 crossrefType "journal-article" @default.
• W2890711618 hasAuthorship W2890711618A5012700479 @default.
• W2890711618 hasAuthorship W2890711618A5016431282 @default.
• W2890711618 hasAuthorship W2890711618A5019258469 @default.
• W2890711618 hasAuthorship W2890711618A5021102458 @default.
• W2890711618 hasAuthorship W2890711618A5034100625 @default.
• W2890711618 hasAuthorship W2890711618A5036692508 @default.
• W2890711618 hasAuthorship W2890711618A5039310160 @default.
• W2890711618 hasAuthorship W2890711618A5042375497 @default.
• W2890711618 hasAuthorship W2890711618A5043887737 @default.
• W2890711618 hasAuthorship W2890711618A5044978887 @default.
• W2890711618 hasAuthorship W2890711618A5048786719 @default.
• W2890711618 hasAuthorship W2890711618A5050089199 @default.
• W2890711618 hasAuthorship W2890711618A5057758368 @default.
• W2890711618 hasAuthorship W2890711618A5061298229 @default.
• W2890711618 hasAuthorship W2890711618A5062535720 @default.
• W2890711618 hasAuthorship W2890711618A5063215262 @default.
• W2890711618 hasAuthorship W2890711618A5078527369 @default.
• W2890711618 hasAuthorship W2890711618A5079081718 @default.
• W2890711618 hasAuthorship W2890711618A5088641329 @default.
• W2890711618 hasConcept C121608353 @default.
• W2890711618 hasConcept C126322002 @default.
• W2890711618 hasConcept C143998085 @default.
• W2890711618 hasConcept C2779974597 @default.
• W2890711618 hasConcept C2908647359 @default.
• W2890711618 hasConcept C512399662 @default.
• W2890711618 hasConcept C526805850 @default.
• W2890711618 hasConcept C71924100 @default.
• W2890711618 hasConcept C99454951 @default.
• W2890711618 hasConceptScore W2890711618C121608353 @default.
• W2890711618 hasConceptScore W2890711618C126322002 @default.
• W2890711618 hasConceptScore W2890711618C143998085 @default.
• W2890711618 hasConceptScore W2890711618C2779974597 @default.
• W2890711618 hasConceptScore W2890711618C2908647359 @default.
• W2890711618 hasConceptScore W2890711618C512399662 @default.
• W2890711618 hasConceptScore W2890711618C526805850 @default.
• W2890711618 hasConceptScore W2890711618C71924100 @default.
• W2890711618 hasConceptScore W2890711618C99454951 @default.
• W2890711618 hasLocation W28907116181 @default.
• W2890711618 hasOpenAccess W2890711618 @default.
• W2890711618 hasPrimaryLocation W28907116181 @default.
• W2890711618 isParatext "false" @default.
• W2890711618 isRetracted "false" @default.
• W2890711618 magId "2890711618" @default.
• W2890711618 workType "article" @default.